Data were then replicated in an independent cohort of patients with related neurodegenerative disorders, confirming six promising DLB biomarkers, namely VGF, SCG2, NPTX2, NPTXR, PDYN and PCSK1N. Here, PDYN is linked to Lewy body dementia.